EHR-facilitated Collaborative Care (Intervention) vs Usual Care (Control): deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measure	Value	95% interval, lower	95% interval, upper	Method	Source
Risk in group 1	0.128	0.124	0.133	wilson	ClinicalTrials.gov
Risk in group 2	0.137	0.132	0.142	wilson	ClinicalTrials.gov
Risk difference, group 1 minus group 2	-0.00851	-0.0153	-0.00181	newcombe hybrid score	ClinicalTrials.gov
Risk ratio, group 1 over group 2	0.938	0.892	0.986	log	ClinicalTrials.gov
Odds ratio, group 1 over group 2	0.929	0.876	0.984	log	ClinicalTrials.gov
Number needed to treat, for one fewer death from any cause on EHR-facilitated Collaborative Care (Intervention) than on Usual Care (Control)	118	65.5	553	from the risk difference interval	ClinicalTrials.gov

Groups 2

Group 2 names the comparator: usual care.

Group	Title	Description	With the outcome	Analysed	ClinicalTrials.gov code	Source
Group 1	EHR-facilitated Collaborative Care (Intervention)	Participants were administered ePROMs during EHR-facilitated collaborative care (ECC) periods. Automated responses, matched to symptom type and intensity, appeared following a patient's report of an actionable symptom, defined as \>=4/10 on a numeric rating scale (NRS). For any actionable symptom, respondents were asked if they wanted to receive symptom-specific self-management resources. For severe symptoms, \>=7/10, respondents were asked if they wanted to work remotely with a Symptom Care Manager (SCM) to develop an individualized symptom management plan.~Participants who responded to \>=2 ePROMs were included in the analytic cohort.	3,192	24,874	EG001	ClinicalTrials.gov
Group 2	Usual Care (Control)	Participants were administered ePROM surveillance alone. Participants who responded to \>=2 ePROMs were included in the analytic cohort.	2,214	16,180	EG000	ClinicalTrials.gov

Harm 2

Field	Value	Source
What it counts	Total, all-cause mortality	ClinicalTrials.gov
Time frame		ClinicalTrials.gov

Trial 8

Field	Value	Source
Title	Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial	ClinicalTrials.gov
NCT number	NCT03892967	ClinicalTrials.gov
Phases	NA	ClinicalTrials.gov
Conditions	Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm	ClinicalTrials.gov
Interventions	Interview, Quality-of-Life Assessment, Questionnaire Administration	ClinicalTrials.gov
Lead sponsor	Mayo Clinic	ClinicalTrials.gov
Results first posted	2025-10-07	ClinicalTrials.gov
Results on ClinicalTrials.gov	https://clinicaltrials.gov/study/NCT03892967?tab=results	ClinicalTrials.gov

Source 4

Field	Value	Source
Release	trial-comparisons-2026-03-23-0.1.0	ClinicalTrials.gov
Release manifest SHA-256	f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57	ClinicalTrials.gov
AACT copy	2026-03-23	ClinicalTrials.gov
Tables read	outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet	ClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.